Prof Jon Watson

STAFF PROFILE

Contact

Publications

Filter by

2019

Leasing a medical curriculum: what's it worth?

David Prideaux, Julie Ash, Simon Broadley, Brendan Crotty, William Hart, Judy Searle, Jon Watson, Lindon Wing, Paul Worley

(2019), Vol. 41, pp. 697-702, Medical teacher, London, Eng., C1

journal
2017

Neocarzinostatin, aptamer conjugates for targeting EpCAM-positive tumor cells

P Athyala, J Kanwar, S Chitipothu, R Kanwar, S Krishnakumar, J Watson, J Narayanan

(2017), Vol. 37, pp. 3615-3629, Anticancer research, Kapandriti Attica, Greece, C1

journal

Cohort analysis of simulation-based medical training for decision support

J Zhang, S Hanoun, B Khan, D Creighton, S Nahavandi, K Britt, K D'Souza, J Watson, R Yanieri

(2017), pp. 2608-2612, SMC 2017 : Proceedings of the IEEE International Conference on Systems, Man, and Cybernetics, Banff, Canada, E1

conference
2016

Probing the biophysical interaction between Neocarzinostatin toxin and EpCAM RNA aptamer

P Athyala, J Kanwar, M Alameen, R Kanwar, S Krishnakumar, J Watson, U Vetrivel, J Narayanan

(2016), Vol. 469, pp. 257-262, Biochemical and biophysical research communications, Amsterdam, The Netherlands, C1

journal
2014

Nurse-led clinic: effective and efficient delivery of assessment and review of patients with hepatitis B and C

M Biddle, N Adler, S Heath, S Streat, M Wardrop, J Watson

(2014), Vol. 44, pp. 581-585, Internal Medicine Journal, Richmond, Vic., C1

journal

Hepatitis C virus treatment in the 'real-world': how well do 'real' patients respond?

N Friedman, J Green, H Weber, S Stephen, S Lane, A Ting, J Watson

(2014), Vol. 4, pp. 214-220, Journal of clinical and experimental hepatology, Gurgaon, India, C1

journal

Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies

Stuart Roberts, Joanne Mitchell, Reynold Leung, David Booth, Steven Bollipo, George Ostapowicz, Andrew Sloss, Geoffrey McCaughan, Gregory Dore, Alexander Thompson, Darrell Crawford, William Sievert, Martin Weltman, Wendy Cheng, Jacob George, Australian Liver Association Clinical Research Net, Johnathan Watson

(2014), Vol. 29, pp. 179-184, Journal of gastroenterology and hepatology, Chichester, Eng., C1

journal
2008

Chronic hepatitis C

J Watson, C Hair

(2008), Vol. 9, pp. 66-67, Medicine Today, C1-1

journal
2000

The tissue effect of argon plasma coagulation on esophageal and gastric mucosa

J Watson, M Bennett, S Griffin, K Matthewson

(2000), Vol. 52, pp. 342-345, Gastrointestinal endoscopy, Amsterdam, The Netherlands, C1-1

journal
1999

Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study

J Watson, D Jones, O James, P Cann, M Bramble

(1999), Vol. 14, pp. 1034-1040, Journal of gastroenterology and hepatology, Chichester, Eng., C1-1

journal
1998

Massively elevated serum ferritin in an ill man with abnormal liver function tests

J Watson, M Bramble, S Ghosh

(1998), Vol. 74, pp. 619-620, Postgraduate medical journal, London, Eng., C1-1

journal
1997

Percutaneous endoscopic gastroenterostomy and jejunal extension for gastric stasis in pancreatic carcinoma

J Watson, K Mannix, K Matthewson

(1997), Vol. 11, pp. 407-410, Palliative medicine, London, Eng., C1-1

journal
1996

Hepatitis C virus: Epidemiology and genotypes in the north east of England

J Watson, A Brind, C Chapman, C Bates, F Gould, S Johnson, A Burt, J Ferguson, P Simmonds, M Bassendine

(1996), Vol. 38, pp. 269-276, Gut, C1-1

journal

Hepatitis C virus infection in the elderly

A Brind, J Watson, O James, M Bassendine

(1996), Vol. 89, pp. 291-296, QJM: an international journal of medicine, Oxford, Eng., C1-1

journal

Non-Hodgkin's lymphoma and hepatitis C virus infection

A Brind, J Watson, A Burt, P Kestevan, J Wallis, S Proctor, M Bassendine

(1996), Vol. 21, pp. 127-130, Leukemia and lymphoma, Abingdon, Eng., C1-1

journal

Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients

J Watson, D Bevitt, G Spickett, G Toms, M Bassendine

(1996), Vol. 25, pp. 599-607, Journal of hepatology, Amsterdam, The Netherlands, C1-1

journal

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

G Dusheiko, J Main, H Thomas, O Reichard, C Lee, A Dhillon, S Rassam, A Fryden, H Reesink, M Bassendine, G Norkrans, T Cuypers, N Lelie, P Telfer, J Watson, C Weegink, P Sillikens, O Weiland

(1996), Vol. 25, pp. 591-598, Journal of hepatology, Amsterdam, The Netherlands, C1-1

journal
1995

Prokaryotic expression and analysis of the antibody response to a Newcastle isolate of the core gene of hepatitis C

I Milton, M Carter, G Toms, J Watson, M Bassendine, K Quo

(1995), Vol. 45, pp. 253-258, Journal of medical virology, Chichester, Eng., C1-1

journal

Funded Projects at Deakin

Industry and Other Funding

Support Funding Appointment for to Head of Research at OrthoSport Victoria Research Unit.

Prof Jon Watson

  • 2019: $144,499
  • 2018: $155,000
  • 2017: $150,000
  • 2016: $100,000
  • 2015: $100,000
  • 2014: $100,000
  • 2013: $50,000

Supervisions

Associate Supervisor
2017

Prasanna Kumar Athyala

Thesis entitled: Oligonucleotide-Conjugates for Targeting EpCAM Positive Tumor Cells

Doctor of Philosophy (Medicine), School of Medicine